Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates

被引:46
|
作者
Moaddel, R
Bullock, PL
Wainer, IW [1 ]
机构
[1] NIA, Bioanalyt & Drug Discovery Unit, Intramural Res Program, Lab Clin Investigat,Gerontol Res Ctr, Baltimore, MD 21224 USA
[2] Purdue Pharma LP, Discovery Support, Ardsley, NY USA
关键词
substrates; ABC transporters; screening; P-glycoprotein;
D O I
10.1016/j.jchromb.2003.10.054
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular membranes from a cell line expressing P-glycoprotein (Pgp(+)) and from a cell line that does not express Pgp (Pgp(-)) were immobilized on the surface of glass capillaries (25 cm x 100 mum i.d.) by non-covalent interactions using the avidin-biotin coupling system to create two open tubular columns, Pgp(+)-OT and Pgp(-)-OT. Frontal displacement chromatography on the Pgp(+)-OT demonstrated that the immobilized Pgp retained its ability to specifically bind the known Pgp substrates vinblastin and ketoconazole. The calculated affinities, expressed as K-d, for vinblastin and ketoconazole were 97 nM and 12.1 muM, which were comparable with previously reported Kd values of 37 nM and 8.6 muM, respectively. The results confirm that the Pgp(+)-OT can be used to quantitatively estimate binding affinities for the Pgp. Frontal displacement chromatography on the Pgp(-)-OT demonstrated that the immobilized membranes retained the ability to bind some Pgp substrates, but that the binding was not due to specific binding to Pgp. A cohort of compounds containing high affinity Pgp substrates (vinblastin, prazosin) and moderate-low affinity Pgp substrates (doxorubicin, verapamil, ketoconazole) and a non-substrate (nicotine) were chromatographed on the Pgp(+)-OT and Pgp(-)-OT using fast frontal analysis and mass spectrometric detection. The results demonstrated that when the retention on the Pgp(+)-OT was corrected by subtraction of the retention on the Pgp(-)-OT, the test compounds could be accurately sorted into high, moderate-low and non-substrate categories. The data from the study indicates that a single 30-min parallel chromatographic experiment can be used to rank a compound based upon its relative affinity for the immobilized Pgp. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [21] Identification of Smac mimetics as novel substrates for p-glycoprotein
    Hugle, Manuela
    Czaplinski, Sebastian
    Habermann, Karoline
    Vogler, Meike
    Fulda, Simone
    CANCER LETTERS, 2019, 440 : 126 - 134
  • [23] Characterisation of β-adrenoreceptor antagonists as substrates and inhibitors of P-glycoprotein
    Bachmakov, I
    Werner, U
    Endress, B
    Auge, D
    Fromm, MF
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 702 - 702
  • [24] A topological substructural approach for the prediction of P-glycoprotein substrates
    Cabrera, MA
    González, I
    Fernández, C
    Navarro, C
    Bermejo, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (03) : 589 - 606
  • [25] How does P-glycoprotein recognize its substrates?
    Ueda, K
    Taguchi, Y
    Morishima, M
    SEMINARS IN CANCER BIOLOGY, 1997, 8 (03) : 151 - 159
  • [26] Chemical Flexibility of P-Glycoprotein for Interaction with Substrates and Modulators
    Chufan, Eduardo E.
    Kapoor, Khyati
    Sim, Hong-May
    Durrell, Stewart
    Ambudkar, Suresh V.
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 200A - 200A
  • [27] Computational models for predicting substrates or inhibitors of P-glycoprotein
    Chen, Lei
    Li, Youyong
    Zhang, Huidong
    Zhang, Liling
    Hou, Tingjun
    DRUG DISCOVERY TODAY, 2012, 17 (7-8) : 343 - 351
  • [28] Characterization of a P-glycoprotein homolog in Schistosoma mansoni
    Messerli, Shanta M.
    Morgan, William
    Spranger, Stefani
    Greenberg, Robert M.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 81 - 82
  • [29] Quantitative evaluation of isothiocyanates as substrates and inhibitors of P-glycoprotein
    Barecki-Roach, M
    Wang, EJ
    Johnson, WW
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (09) : 1251 - 1257
  • [30] Characterization of P-glycoprotein transport and inhibition in vivo
    Barbarics, E
    Kronauge, JF
    Cohen, D
    Davison, A
    Jones, AG
    Croop, JM
    CANCER RESEARCH, 1998, 58 (02) : 276 - 282